Tumors of Major and Minor Ampulla

Published on 20/03/2015 by admin

Filed under Pathology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1451 times

Chapter 41

Tumors of Major and Minor Ampulla

N. Volkan Adsay

Olca Basturk

Introduction

Tumors of the ampulla of Vater are pathologically and clinically significant (Box 41.1). Because the distal common bile duct and the main pancreatic duct converge at the level of the ampulla, tumors may obstruct two organs, leading to early onset of symptoms. The potential for early detection has improved the prognosis for neoplasms of the ampulla. However, the newer techniques used for local treatment, such as endoscopic polypectomy and transduodenal ampullectomy,13 have created challenges in the pathologic analysis of ampullary tumors.

Anatomic and Histologic Considerations

In this chapter, the term ampulla refers to the whole ampullary structure, including all four compartments (Table 41.1). The word papilla refers to the pinnacle (edge) of the ampullary prominence (see Figs. 41.1 and 41.3). For lesions that arise from or are localized preferentially at the duodenal surface of the ampulla, the term ampullary duodenum is used. Although the term periampullary duodenum has been used in publications to describe this region,4 it is not used in this chapter to avoid confusion.

The anatomy of the ampulla of Vater can vary considerably between individuals, but in most, the common bile duct and the main pancreatic duct join into a common channel within the wall of the duodenum. Flow of luminal material through the ampulla is regulated by dense fascicles of smooth muscle, called the sphincter of Oddi (Fig. 41.1, A). The mucosa forms folds called plicae. Although the length of the common channel varies,5 it is less than 3 mm long in most persons. In some individuals, the common bile duct and main pancreatic duct are separated by a septum. These anatomic variations are difficult to demonstrate in the routine examination of surgical specimens5a unless dye injection or specimen radiographs are performed.

image
FIGURE 41.1 A and B, Histologic constituents of the ampulla pertinent to tumor classification. The duodenal surface of the ampulla (1) is lined by intestinal epithelium. The papilla of Vater (2), which is the prominence where the tips of the two ducts transition into duodenal mucosa, exhibits mixed epithelia, including specialized epithelium with mucinous features and goblet cells (see Fig. 41.3). In the wall of the ampulla, pancreatobiliary-type ductules (3) are embedded in the dense musculature of the sphincter of Oddi. The very distal segments of the common bile duct and main pancreatic duct contain various amounts of peribiliary or tributary ductules (4).

The minor ampulla is also subject to anatomic variations. It is typically located 2 cm proximal and anterior to the major ampulla within the duodenum (Fig. 41.2, A). It can be mistaken for a polyp endoscopically. The dorsal pancreatic duct drains through the minor ampulla. Although this duct normally regresses with fetal maturation, residual duct elements remain in the submucosa of the duodenum in most individuals. The minor ampulla is patent in 40% of the population.6,7 Composition of the minor ampulla varies among individuals.

The epithelium of the major and minor ampullae is the small intestinal type on the duodenal surface (Fig. 41.3; see Fig. 41.1). At the edge of the ampullae, where the ducts transition to the duodenal surface (i.e., the papilla), a specialized epithelium with features that resemble gastric-foveolar epithelium with scattered goblet cells is usually seen (see Figs. 41.1, B and 41.3, B). Because of mucinous epithelium, biopsy specimens from this area can be mistaken as representing peptic injury. Pancreatobiliary-type tributary ductules occur in the wall of the ampulla (see Fig. 41.1, B). These structures are usually embedded in dense myoid tissue of the sphincter of Oddi or duodenal musculature (see Fig. 41.1, B).8 The epithelium of the papilla transitions into ductal epithelium. Pancreatic acinar lobules often reside in the wall of the ampulla (see Fig. 41.3, C). They may contain islets of Langerhans. Clusters of neuroendocrine cells may also occur in the minor ampulla but only seldom in major ampulla.9,10

Classification of Ampullary Tumors

Various criteria to determine whether a particular tumor originates in the ampulla or in the nonampullary duodenum are offered in the literature. Inconsistent use of the term periampullary has further complicated the issue. In some publications, it refers to the ampullary region proper, whereas in others, it is used to describe the nonampullary segment of the duodenum.11,12 In the staging section of the protocol for the examination of ampullary tumor specimens published by the College of American Pathologists (CAP),13 only tumors that are intraampullary (i.e., developing within the cavity) are regarded as truly ampullary in origin, whereas in the tumor classification section, other anatomic subregions (e.g., periampullary duodenal, papilla of Vater) are also recognized as part of the ampulla.

In a more specific definition of the ampulla,4,14 tumors are defined as ampullary if more than 75% of the tumor is localized to or engulfed by the ampulla and the preinvasive component (if any) is localized within one of the four compartments of the ampulla. The four subsets of ampullary tumors (i.e., ampullary-NOS, intraampullary papillary-tubular neoplasm associated, ampullary duct, and ampullary duodenum) are classified according to their primary site of growth4,14 (Table 41.2; see Figs. 41.2 and 41.4 through 41.6):

Table 41.2

Macroscopic Properties of Ampullary Tumors4,14

Subtype of Ampullary Carcinoma Luminal Findings Status of Ampullary Orifice Cut Section Appearance Findings in Distal Segments of the Common Bile and Pancreatic Ducts
Ampullary-NOS (papilla of Vater) Ulceration and/or polypoid lesion localized in the ampulla Centrally located White, firm lesion involving the papilla of Vater Nondescript tumor involvement of the distal tips
Intraampullary papillary-tubular neoplasm associated Dilated ampullary orifice with protruding polypoid, granular material Centrally located; dilated orifice, easy to probe Preinvasive (polypoid or granular), exophytic lesion within ampullary channel and distal segments of the ducts Filled with papillary, nodular, or granular material; often significantly dilated
Ampullary duct Minimal changes; button-like mucosal-covered elevation or subtle ulceration or minimal granulation Centrally located; often relatively difficult to probe Scirrhous, plaquelike, constrictive, and often subtle lesion on the wall of the papilla of Vater and distal segments of the ducts Scarlike firmness on the walls, often concentric
Ampullary duodenum Prominent ulcerovegetative nodules on the duodenal surface of the ampulla Eccentrically located; difficult to probe in some cases, especially if invasive Granular, nodular tumor on the duodenal surface, pushing into the inner structures Variable secondary destruction by invasion of the duodenal surface lesion

image

NOS, Not otherwise specified.

image
FIGURE 41.4 Intraampullary tubular-papillary neoplasm–associated invasive carcinoma.4,5a,14 A, The ampullary orifice is markedly dilated. White, granular mucosa involves the papilla of Vater and protrudes into the duodenum. The probe in the common bile duct indicates the ampullary orifice. The bulge on the left, which is covered by duodenal mucosa (arrows), is caused by the underlying tumor that fills the ampullary channel. B, On sectioning, the bulk of the lesion was found to be localized within the distal segment of the common bile duct (CBD) and main pancreatic duct (PD), forming a granular, polypoid, exophytic lesion (arrows). The duodenal mucosa was mostly uninvolved. Beige-tan areas of this polypoid or nodular lesion represented preinvasive neoplasm, whereas the white-gray area (star) was found to be invasive carcinoma on microscopic examination.
image
FIGURE 41.6 Subtypes of ampullary carcinoma can be determined by careful gross examination.4,5a,14 The diagrams indicate preinvasive tumor (gray) and invasive tumor (black) areas. Arising in the papilla of Vater, ampullary carcinoma may be classified as not otherwise specified (AMP-NOS). Intraampullary papillary-tubular neoplasm–associated carcinomas (Intra-AMP) are characterized by a prominent preinvasive neoplasm that grows predominantly as an exophytic mass within the ampullary channel (i.e., distal ends of the common bile duct and main pancreatic duct). In contrast, ampullary duct (AMP duct) carcinomas show minimal or no preinvasive lesion, and instead form a plaquelike stricture at the distal ends of the ducts. Ampullary duodenum carcinomas (AMP duodenum) form ulcerovegetative tumors that grow predominantly (>75%) on the duodenal surface of the ampulla.

Preinvasive Neoplasms

Adenomas of the Ampullary Duodenum

Adenomas of the intestinal type, similar to colorectal adenomas, occur in the ampullary duodenum (i.e., duodenal surface of the ampulla).15 In the small intestine, the ampulla is a particularly common site of adenoma development,16 presumably because this is an anatomic site that is prone to chemical or physical injury. Most ampullary adenomas are sporadic, but the ampullary and other parts of the duodenum are the most common sites of extracolonic adenomas in patients with familial adenomatous polyposis (FAP).1721 Between 80% and 90% of patients with FAP develop multiple adenomas in the duodenum, and 25% have them in the ampullary duodenum. Symptomatic adenomas are usually detected within 10 to 15 years of colectomy in these patients.20 Fortunately, because FAP screening protocols include periodic endoscopic surveillance of the duodenum, adenomas are increasingly detected at an earlier stage of development, while they are asymptomatic.22

Adenomas of ampullary duodenum often extend into the papilla and distal common bile duct and may involve the ductules in the wall of the papilla. More than 75% of the lesion should be located on the duodenal surface of the ampulla to be classified as an adenoma of the ampullary duodenum. Those with complete or near-complete intrapapillary growth are classified as intraampullary papillary-tubular neoplasms.

Clinical Features

Patients with sporadic adenomas of the ampullary duodenum are an average of 60 years. In contrast, FAP patients are typically 20 years younger at the time of diagnosis.16,2326 Sporadic cases have a female predilection, whereas both sexes are affected equally by FAP.17,18,20,22 Clinical symptoms vary. Larger adenomas may cause bile duct obstruction with jaundice, abdominal pain, and pancreatitis. Smaller adenomas are often asymptomatic. Gastrointestinal hemorrhage is rare and raises concerns regarding the existence of an invasive carcinoma.

Histologically, tubular, villous, and tubulovillous adenomas occur with equal frequency in the sporadic cases, but tubular adenomas are more common in patients with FAP. Villous adenomas tend to be larger than tubular or tubulovillous adenomas. The prevalence of carcinoma in adenomas increases proportionately with the size of the polyp, and villous adenomas are more likely to harbor a carcinoma.

Pathologic Features

Grossly, most tubular adenomas of ampullary duodenum are bosselated in appearance, whereas most villous adenomas have a feathery or papillary appearance (Fig. 41.8).27,28 Villous adenomas are usually larger than tubular adenomas. Adenomas of the ampullary duodenum are more likely to harbor an invasive carcinoma than similarly sized colorectal adenomas. A firm texture or surface ulceration raises concern about an invasive component. Invasive carcinomas that arise in adenomas are often hidden in the deep creases of the tumor at the base of the polyp and are difficult to detect in surface biopsies.

Microscopically, adenomas of the ampullary duodenum are similar to those that occur in the large intestine. They have complex glands and villi (papillae) lined by mucin-depleted columnar cells with elongated, hyperchromatic, pencil-shaped nuclei and nuclear pseudostratification. The amount of cytoplasmic mucin varies. Goblet cells may be seen, but they typically are not numerous. The appearance of some FAP-related cases may be subtle and may even show surface maturation.

Adenomas are classified as tubular, tubulovillous, or villous, depending on the amount of glandular and papillary architecture. Tubulovillous adenomas contain more than 25% villi,15 and villous adenomas contain more than 75% villi. Tubular, villous, and tubulovillous adenomas occur with equal frequency in sporadic cases, but tubular adenomas are more common in patients with FAP.1722

By definition, all adenomas are dysplastic. Dysplasia is categorized as low or high grade, depending on the degree of cytologic and architectural atypia and complexity of the epithelium. Low-grade dysplasia consists of pseudostratified, relatively monotonous columnar cells with cigar-shaped, elongated nuclei. The nuclei are lined up in the basal aspect of the cell cytoplasm, and there is no or only mild pleomorphism and loss of nuclear polarity. High-grade dysplasia is characterized by marked nuclear pleomorphism, loss of cell polarity, increased nucleus-to-cytoplasm ratio, and increased mitoses combined with architectural complexity, such as cribriforming, back-to-back glands, and micropapillae formation.

Paneth cells and neuroendocrine cells are particularly common in all ampullary adenomas, and in some cases, they can form more than 50% of the neoplastic cell popu­lation, particularly in FAP cases. Immunohistochemical staining typically reveals evidence of intestinal differentiation, such as positivity for cytokeratin 20 (CK20), CDX2, and MUC2.29 CK7 is also commonly positive in these tumors.29,30 Paneth cells label for lysozyme, and the endocrine cell component can be detected with chromogranin or synaptophysin.20,29,31,32

Differential Diagnosis

Extension of adenomatous epithelium into the ductules in the wall of the papilla can simulate invasive carcinoma (Fig. 41.9), particularly where continuity with the normal surface epithelium is lost, and high-grade dysplasia is found. Because of the complexity of these ductular structures, it can be difficult or impossible to distinguish in situ disease from true invasion (see Fig. 41.9). Findings such as paradoxical differentiation (i.e., different cytomorphology in the preinvasive and invasive components), cuboidal epithelium, dispersion in a nonlobular and nonorganoid fashion, marked contour irregularities, formation of complex micropapillary tufts or markedly elongated gland units, and severe cytologic atypia favor invasive carcinoma (Table 41.3). Budding and vascular or perineural invasion are helpful findings. However, invasion can be expansile (i.e., nodular or pushing border), not showing the conventional infiltration patterns.

Another diagnostic dilemma arises when an underlying invasive carcinoma of the pancreas or bile duct involves the ampullary epithelium by colonization (“cancerization”) of the mucosal basement membrane, which simulates in situ disease (Fig. 41.10), in a process called pseudoadenomatous transformation. Because carcinomas usually have pancreatobiliary (rather than intestinal) differentiation, immunohistochemical staining may reveal positivity for only CK7 (rather than CK7 and CK20) and for MUC1 (rather than MUC2 and CDX2).29 Immunohistochemical stains can help to demonstrate that both components have the same immunophenotype.

Reactive changes associated with inflammatory processes of the ampulla can mimic an adenoma (Fig. 41.11). In addition to having associated inflammation, reactive atypia usually lacks the degree of nuclear elongation and pseudostratification of adenomas. Paradoxically, reactive nuclei occasionally show more atypia than low-grade adenomas in the form of enlargement and macronuclei, but the high degree of architectural complexity characteristic of high-grade dysplasia is not usually seen in reactive epithelium. Reactive changes often have a higher degree of cytoplasmic eosinophilia, presumably because of retaining normal organelles instead of forming abnormal mucins compared with adenomas.

Adenomatous lesions that occur within the papilla and distal common bile duct (i.e., IAPNs) are similar in appearance to primary pancreatic and biliary intraductal neoplasms. They have several distinctive characteristics that distinguish them from adenomas of the ampullary duodenum.

Intraampullary Papillary-Tubular Neoplasms

IAPNs are adenomatous (tumoral, intraepithelial, neoplastic) lesions that occur almost exclusively in the ampulla (see Fig. 41.4).14,33 They represent the intraampullary counterpart of intraductal neoplasms of the pancreas and biliary tract (see Chapters 38 and 40). Included in this category of tumors are noninvasive pancreatobiliary neoplasms and intestinal-type adenomas in the ampulla.34 Papillary or polypoid tumors can fill the ampullary channel and distal segment of the common bile duct or main pancreatic duct (see Fig. 41.4). By definition, involvement of the ampullary duodenum and intramucosal extension into the proximal aspect of the common bile duct and main pancreatic duct is minimal (<25%).

Clinical Features

These tumors account for one third of resections performed for a clinical diagnosis of ampullary tumor. The mean age of affected patients is 64 years (range, 27 to 85 years), and the tumors occur predominantly in men (male-to-female ratio of 2.2). Symptoms (e.g., jaundice, pruritus, light stool, dark urine) are usually related to obstruction of the common bile duct, but patients also may have nonspecific symptoms such as abdominal pain and weight loss.

Pathologic Features

Gross examination of the ampullary duodenum5a typically reveals a hemispheric elevation of intact mucosa, often with a patulous papilla orifice from which nodules of friable granular material protrude into the duodenal lumen (see Fig. 41.4, A). A probe inserted into the common bile duct or main pancreatic duct typically extends into the center of the lesion. Ulceration may be evident, but overt mucinous discharge, characteristic of pancreatic intraductal neoplasms, is seldom encountered. On sectioning, the tumors are characterized by a prominent exophytic growth pattern in the dilated distal bile and pancreatic ducts (see Fig. 41.4B). Obstructive polypoid and light tan, granular nodules, which are often associated with dilation of upstream biliary or pancreatic ducts, may be identified (see Fig. 41.4B). The mean tumor diameter is 2.9 cm.

Microscopically, IAPNs show various degrees of papillary or tubular growth (Figs. 41.12 through 41.14). Most have a mixture of these patterns. They exhibit a spectrum of dysplasia, and most cases show a mixture of low- and high-grade dysplasia. The criteria used for low- and high-grade dysplasia is the same as that used for adenomas of ampullary duodenum (discussed earlier). However, some cases exhibit gastric differentiation (see Fig. 41.14) similar to that of intraductal and intracholecystic tumors of the pancreatobiliary tract and foveolar and pyloric adenomas of the stomach. These cases may lack overt cytologic atypia characteristic of intestinal-type adenomas. In most cases, examination reveals foci of high-grade dysplasia. High-grade dysplasia correlates with a papillary configuration. Unlike adenomas of the ampullary duodenum, approximately 50% of IAPNs show mixed (intestinal, gastric, pancreatobiliary) differentiation.

Approximately 75% of IAPNs are associated with invasive carcinoma at the time of diagnosis, but the invasive component is usually less than 1 cm in diameter. Invasion is mostly tubular and often shows a mixture of intestinal (Fig. 41.15) and pancreatobiliary features (Fig. 41.16). The histologic type of invasive carcinoma parallels that of the preinvasive component in many but not all cases.

The hybrid nature of these lesions is reflected in their immunophenotype. More than 50% of cases coexpress CK7 and CK20. Immunostaining for MUC2 and CDX2 is positive in cases with intestinal differentiation. Results for MUC1, MUC5AC, and MUC6 are positive in cases with gastropancreatobiliary differentiation. However, overlaps are common, and a significant proportion of the cases reveal mixed immunophenotype.14

Differential Diagnosis

The most challenging aspect of these lesions is to differentiate invasion from pseudoinvasion. The preinvasive component of these lesions often involves the (tributary) ductules in the wall of the ampulla. The criteria for identifying invasion in adenomas of the ampullary duodenum are applicable in this case (see Table 41.3).

Differentiating IAPNs from their pancreatic and biliary counterparts or adenomas of the ampullary duodenum requires knowledge of the location and distribution of the neoplastic lesion. A nonintestinal phenotype is helpful in distinguishing these lesions from adenomas of the ampullary duodenum, because examination of the latter invariably reveals intestinal differentiation.

Natural History and Prognosis

Noninvasive cases have an excellent prognosis. However, cases with extensive high-grade dysplasia without invasion have recurred. Long-term follow-up is warranted, even in noninvasive cases.

Cases with invasive carcinoma are associated with better survival than conventional (invasive) ampullary carcinomas unaccompanied by an IAPN (3-year survival of 69% versus 44%).14 This survival advantage is likely attributable to early detection of invasion but also reflects differences in tumor biology.4,14,35

Flat Dysplasia

Some ampullary carcinomas arise from flat dysplasia instead of developing from an adenomatous polyp.15 In rare cases, dysplastic epithelial cells grow along the ducts at the periphery of an invasive carcinoma. Flat dysplasia of the ampulla in the absence of invasive carcinoma is rarely seen, presumably because these lesions do not obstruct the ampulla and are usually asymptomatic.

Invasive Adenocarcinomas

Because of the proximity of anatomic structures in the ampulla, it is often difficult to grossly and microscopically distinguish tumors that arise in the distal common bile duct from those that arise in the duodenum, pancreatic head, or true ampulla. Published data regarding ampullary neoplasms often contain references to periampullary tumors. In some studies, the term periampullary is used to define all tumors located in pancreatoduodenectomy specimens, whereas in others, the term is used for pure ampullary tumors. In other publications, the term periampullary refers only to nonampullary segments of the duodenum.11,12,3638

Classification

The synoptic reporting document of the CAP13 recog­nizes three categories of ampullary tumors: periampullary-duodenal, papilla of Vater, and intraampullary. However, the tumor-node-metastasis (TMN) staging protocol of the American Joint Committee on Cancer (AJCC),39 which is endorsed by the CAP, considers only intraampullary tumors as ampullary in origin.39 The three categories of tumors recognized by the CAP were further divided into four groups,4 and ampullary carcinomas are classified as follows.

I. Primary ampullary carcinomas (Table 41.4; see Table 41.1)

A. Ampullary carcinomas not otherwise specified (ampullary-NOS) include tumors that are presumed to arise from the papilla of Vater (i.e., the edge of mucosa where the common bile duct and main pancreatic duct merge into the duodenal mucosa) (see Fig. 41.7). Almost 50% of cases that occur in the ampulla fall into this category, presumably because this group of tumors includes those that arise in the papilla of Vater and those that cannot be confidently placed into one of the subsequent categories. With improved gross examination skills and careful evaluation, the percentage of cases in this category is expected to decrease significantly.

B. Carcinomas associated with IAPNs are characterized by preinvasive nodules located in the ampullary channel (i.e., distal tip of the common bile duct and main pancreatic duct). Gross examination often reveals light tan, friable nodules (see Fig. 41.4). From the duodenal perspective, these tumors show a dilated orifice, from which granular material often protrudes into the lumen of the bowel. Probes placed into the common bile duct and pancreatic duct typically exit into the center of the lesion. Microscopic examination often reveals only a small invasive carcinoma, and the prognosis is relatively good, especially if there is no invasive carcinoma or invasion is limited in amount.

C. Carcinomas of ampullary ducts are scirrhous lesions that circumferentially constrict the distal end of the common bile duct and pancreatic duct, with preservation of the papilla of Vater and ampullary duodenal mucosa. From the duodenal perspective, these tumors typically show a button-like elevation of mucosa or a small, ulcerating lesion (see Fig. 41.2). Microscopically, they often prove to be pancreatobiliary-type carcinomas. Although these tumors are usually less than 2 cm in diameter, they have an aggressive behavior, the worst among the ampullary carcinoma subtypes but significantly better than pancreatic ductal adenocarcinomas.

D. Carcinomas of the ampullary duodenum (i.e., periampullary-duodenal tumors) arise from the ampullary duodenum, usually from an adenoma of the ampullary duodenum, forming bulky lesions in which the ampullary orifice is often eccentrically located (see Fig. 41.5). They typically have an intestinal (see Fig. 41.15) or mucinous-intestinal phenotype. Although they are usually very large and produce lymph node metastases, their behavior is often better than expected.

Table 41.4

Clinicopathologic Features of Ampullary Carcinomas14,15

Feature AMP-NOS Intra-AMP AMP Duct AMP Duodenum
Site-specific Percentage (%) 55 25 15 5
Baseline Demographics
Mean age 65 64 69 59
Sex (M/F ratio) 1.5 2.2 0.9 1
Clinical Characteristics
Overall tumor size (cm) 2.5 2.9 1.9 4.7
Invasive tumor size (cm) 1.8 1.5 1.7 3.4
Invasive histology (intestinal/nonintestinal ratio) 0.4 1.2 0.06 3
Lymph node metastasis (%) 42 28 41 50
T stage (T1+T2/T3+T4 ratio) 1.6 5.8 0.6 2
Survival Rates
1 year (%) 80 88 80 80
3 year (%) 54 73 41 69
5 year (%) 39 53 29 55

image

AMP duct, Ampullary duct carcinoma; AMP duodenum, ampullary duodenum carcinoma; AMP-NOS; ampullary carcinoma not otherwise specified; intra-AMP, intraampullary papillary-tubular neoplasm associated; F, female; M, male; T, tumor stage.

II. Secondary ampullary carcinomas

A. Duodenal

B. Common bile duct

C. Pancreatic duct

III. Mixed or undetermined origin

Clinical Features

Most malignant neoplasms of the ampulla of Vater are adenocarcinomas. The ampulla is the most common site of all small intestinal adenocarcinomas.23 Overall, approximately 5% of gastrointestinal carcinomas arise from the ampulla.40

Adenocarcinomas develop mainly in adults (mean age, 62 years) and are more common in men than women.40 The estimated lifetime incidence of an ampullary carcinoma is 0.01% to 0.04%.41 Ampullary adenocarcinomas in patients with FAP are diagnosed in younger patients (mean age, 47.5 years). In FAP cases, ampullary adenocarcinomas usually are associated with other neoplasms. Almost 20% of these patients have multiple primary neoplasms.15

Most patients with ampullary adenocarcinoma have symptoms of biliary obstruction. Jaundice accompanied by a palpable, distended gallbladder (i.e., Courvoisier sign) is a classic presentation of ampullary adenocarcinomas, although this constellation of symptoms affects only 15% of patients with these tumors.4143 Other common symptoms include abdominal pain, weight loss, nausea, and acute or chronic pancreatitis.15 Because even small tumors may obstruct the bile duct, ampullary carcinomas often are less than 2 cm in diameter at the time of diagnosis.44,45

Pathologic Features

The gross findings of ampullary carcinomas vary according to subtype4,5a,14 (see Figs. 41.2 and 41.4 through 41.6). IAPN-associated carcinomas are characterized by granular, polypoid material that fills the ampullary channel (i.e., distal segments of the common bile duct and main pancreatic duct). These tumors protrude into the duodenal lumen through a dilated orifice (see Fig. 41.4).

Carcinoma of the ampullary duodenum usually manifests as a large, polypoid, and ulcerovegetative mass on the duodenal surface of the ampulla. The orifice of the ampulla is usually located eccentrically in the proximal aspect of the tumor (see Fig. 41.5). In contrast, ampullary duct carcinomas show minimal changes (from the duodenal perspective) such as a button-like mucosal-covered elevation or a small, flat ulcer, and some show subtle and relatively small, plaquelike areas that circumferentially constrict the distal segments of the common bile duct and main pancreatic duct (see Fig. 41.2). Ampullary-NOS carcinomas are often ulcerated, polypoid tumors localized at the papilla of Vater proper. These tumors usually do not show features characteristic of the other subtypes of ampullary tumors.

Ampullary carcinomas are often associated with dilation of the common bile duct and sometimes of the main pancreatic duct. Ductal dilation is usually most striking in cases with a prominent preinvasive component, particularly in IAPNs or tumors of the ampullary duodenum. It is least prominent in ampullary duct tumors. Most ampullary carcinomas are resected by pancreatoduodenectomy. The margins are not usually involved. Extensive ampullary carcinomas are typically unresectable because of distant metastases.

Microscopically, ampullary adenocarcinomas are highly versatile in their morphologic appearance. The microscopic appearance of ampullary adenocarcinomas reflects their origin in intestinal and biliary epithelium, and hybrid phenotypes are identified (see Figs. 41.1, B and 41.3, B). Most invasive adenocarcinomas are tubular. Some are intestinal-type tumors15,40,46,47 that are similar to conventional colonic adenocarcinomas (see Fig. 41.15). Those that resemble pancreatic or bile duct adenocarcinomas are called pancreatobiliary-type adenocarcinomas (see Fig. 41.16). Other histologic types of carcinoma (discussed later) include mucinous (colloid) carcinoma (Fig. 41.17), poorly cohesive carcinoma (with or without signet ring cells) (Fig. 41.18), micropapillary adenocarcinoma (Fig. 41.19),48 clear cell carcinoma, adenosquamous carcinoma, poorly differentiated and undifferentiated carcinomas (Fig. 41.20).15

Intestinal-type adenocarcinomas are commonly associated with intestinal-type adenomas. Although they may have any type of gross pattern, most carcinomas of the ampullary duodenum are the intestinal type. Histologically, they are composed of individual glands and cribriform nests of tumor cells with an associated desmoplastic stromal response (see Fig. 41.15). Luminal necrosis is a common feature. The neoplastic glands are often elongated and branched. Many cases exhibit an expansile growth pattern. The cells are columnar and have various amounts of cytoplasmic mucin. Well-differentiated cases may also contain goblet cells. The nuclei are typically elongated, pseudostratified, and have moderate to marked pleomorphism. Rarely, Paneth cell differentiation may be seen,49 and extracellular mucin pools may be identified. An extensive mucinous component (>50% of the tumor volume) justifies a diagnosis of mucinous adenocarcinoma (see Fig. 41.17). Solid nests of cells and single cells are characteristic of poorly differentiated cases (see Fig. 41.20).

Pancreatobiliary-type adenocarcinomas are more commonly associated with an ampullary duct preneoplastic component, usually the flat type,4 consistent with the hypothesis that they arise from the terminal pancreatic or biliary ducts. Some arise from IAPNs, adenomas of the papilla of Vater, or the duodenal adenomas.

Examination of pancreatobiliary-type adenocarcinomas usually reveals a proliferation of individual glands that are relatively small, remarkably well formed, and widely separated and that infiltrate within an extensively desmoplastic stroma (see Fig. 41.16). Some glands are more complex, showing papillary or micropapillary projections. Cribriform glands also may be seen. The cytoplasm of tumor cells contains mucin that in some cases may impart a foamy, clear cell appearance to the tumor. The nuclei are round and moderately atypical. They usually lack the characteristic pseudostratification pattern of intestinal-type adenocarcinomas.

Because the ampulla is a transitional region, it is not surprising that many ampullary carcinomas have a mixed phenotypic appearance. In fact, a significant proportion of cases are difficult to place into one of the categories as intestinal or pancreatobiliary, and there is also significant interobserver variability.14,49a Different regions of a single tumor may show different patterns of growth. Budding is common in all ampullary carcinomas, and areas of budding often exhibit pancreatobiliary-like morphology.50

Ancillary Diagnostic Tests and Molecular Properties

With immunohistochemical staining, ampullary adenocarcinomas express keratins and glycoproteins, some of which vary according to the particular histologic type of tumor. Intestinal-type adenocarcinomas express markers of intestinal differentiation, such as CDX2 and MUC2; CK7 expression varies, and MUC1 staining is usually negative.51 The immunophenotype of pancreatobiliary-type adenocarcinomas resembles that of pancreatic and biliary carcinomas, showing consistent expression of CK7, CK19, and MUC1, whereas staining for MUC2 and CDX2 is usually negative.51 Hybrid (transitional) tumors show a mixed immunophenotype. For example, almost 50% of cases coexpress CK7 and CK20. A variety of glycoproteins, such as carcinoembryonic antigen and B72.3, may be expressed in any histologic subtype. Stains for chromogranin or synaptophysin may reveal scattered neuroendocrine cells in all subtypes.

Other histologic types of carcinoma have an immunophenotype that corresponds to the line of differentiation. For instance, squamous areas within adenosquamous carcinomas express squamous lineage markers such as P63 and K903. Mucinous carcinomas may acquire MUC2 and MUC6 expression. Poorly cohesive carcinomas (with or without signet ring cells) show strong MUC5AC positivity, as some do for MUC6, but they typically lack intestinal differentiation, as indicated by MUC2 and CDX2 positivity. Micropapillary adenocarcinomas show CK7 positivity and reversal of cell polarity with MUC1 (i.e., stroma-facing surface of the cells are positive). Undifferentiated and sarcomatoid carcinomas lose cytokeratin expression but acquire vimentin positivity.

Molecular Features

Ampullary carcinomas reveal molecular alterations similar to those of ductal adenocarcinomas of the pancreas and colorectum.52 KRAS mutations are found in approximately 40% of cases. The pattern of specific mutations is similar to that of colorectal carcinomas.5256 Increased expression of TP53 is detected in 70% of cases.53,5760 Sixty-four percent of ampullary carcinomas that arise in FAP contain APC gene mutations, but only 17% of sporadic ampullary carcinomas have mutations in this gene.61 Mutations of the β-catenin gene (CTNNB1) are also uncommon.62 Alterations of the SMAD4 (DPC4) gene are rare in ampullary carcinomas.63 A small proportion of poorly differentiated ampullary carcinomas with morphologic features that resemble medullary carcinomas of the large bowel demonstrate microsatellite instability,63a and in fact, a recent study63b has shown that loss of DNA mismatch repair proteins may be as common as in colorectal cancers, although the earlier literature had conflicting results on this.51,64 In most of these studies, carcinomas arising in different compartments of the ampulla and those with various histologic types, including intestinal and pancreatobiliary, have been analyzed indiscriminately.

Differential Diagnosis

The differential diagnosis of ampullary tumors includes primary tumors of adjacent structures. Gross evaluation is critical to determine the primary site of origin of any tumor of this region, and some guidelines for this have been proposed recently.5a With the principle that most tumors expand uniformly from their site of origin, it is presumed that the center of a neoplasm represents the true primary site. Careful examination of the luminal aspect of the duodenum and well-oriented tissue sections of the ampulla helps to determine the relationship of the tumor to normal anatomic structures.

When distinguishable from mucosal colonization by an underlying invasive carcinoma (see Fig. 41.10), the location of a residual preinvasive neoplasm suggests its site of origin. Well-developed intestinal differentiation in tumors suggests an ampullary origin, because this feature is virtually nonexistent in primary pancreatic and common bile duct carcinomas. However, there is extensive overlap in the histologic, immunophenotypic, and molecular alterations among carcinomas of the ampulla, pancreas, and bile duct. Therefore, careful dissection and sampling of the pancreatoduodenectomy specimen is crucial for determining the precise origin of the tumor.5a

Natural History and Treatment

Ampullary carcinomas have an overall survival rate far better than pancreatic and distal common bile duct cancers. The 5-year survival rate is approximately 40%.4,65,66 Rates of survival appear to be even better than for nonampullary duodenum cancers.67 This rate may be the result of early detection. Some studies have shown a more favorable outcome for stage-matched pure ampullary carcinomas compared with pan­creatic tumors.68 However, this may not be an accurate comparison because the staging parameters used for the two tumors are quite different. Nevertheless, ampullary carcinomas are commonly diagnosed early. Their strategic location at the junction of the common bile duct and main pancreatic duct causes symptoms early in the course of disease.

Ampullary carcinomas often arise from a precursor (adenomatous) lesion, and the mean size of the invasive component is usually significantly smaller than primary pancreatic carcinomas.65 Surgical resectability is an important factor. Positive margins occur in less than 5% of ampullary carcinomas,65 compared with at least 35% of pancreatic tumors. Tumor cell biology may also be a factor in survival rates for ampullary and pancreatic tumors. Some studies have shown that pancreatobiliary-type adenocarcinomas of the ampulla have a worse prognosis than tumors with intestinal differentiation.12,30,69,70 Even pancreatobiliary-type adenocarcinomas that arise in the ampulla have a better prognosis than those that arise from the pancreas or common bile duct, likely because of early detection.4,65

Site-specific subcategories of ampullary tumors have distinct biologic and prognostic properties.4 For instance, IAPN-associated invasive carcinomas often have only a small invasive component (mean, 1.5 cm). Not surprisingly, they have a better prognosis.5a,14 Tumors of the ampullary duodenum are typically associated with a prominent preinvasive component, and although they usually are high stage (i.e., very large size with lymph node metastasis), their prognosis is fairly good. In contrast, ampullary duct tumors often reveal a small (most are <2 cm), invasive carcinoma but still exhibit aggressive behavior. Although ampullary duct tumors are invariably of the pancreatobiliary type, they still have a significantly better prognosis than primary pancreatic or distal bile duct carcinomas.4,66

Other factors associated with prognosis include histologic grade, size of invasive carcinoma, pathologic stage, an adenomatous component,14 and tumor budding.50 Abnormal DNA ploidy, increased tumor proliferation rate, and lymphovascular invasion also have been associated with a poor prognosis.51,7175

Uncommon Carcinomas

Most uncommon tumors are similar to intestinal- and pancreatobiliary-type carcinomas in terms of their clinical presentation, natural history, and prognosis. The following histologic subtypes are important mainly because of their distinct morphologic patterns of growth.

Mucin production is noted in about 15% of ampullary carcinomas45,76,76a and 10% qualify as mucinous carcinoma, with >50% stromal mucin deposition (see Fig. 41.17). These are mostly mixed-mucinous carcinomas. True colloid carcinomas, in which the carcinoma cells are almost all floating within the mucin, are very uncommon. Mucinous carcinomas of the ampulla are seen more commonly in men and tend to arise from the ampullary duodenum.15 The carcinoma cells often reveal intestinal (rather than pancreatobiliary) phenotype, which is also illustrated by frequent positivity of MUC2 and CDX2. A significant proportion of the cases have mixed ordinary (tubular) adenocarcinoma component. Signet ring cells may be prominent, either confined within the mucin lakes (mucinous signet-ring cell carcinoma), or sometimes infiltrating as cellular/non-mucinous infiltrates into the stroma. Mucinous carcinomas are often fairly large and two-thirds have lymph node metastasis at presentation, but their behavior appears to be less aggressive than what would be expected from advanced tumors. Of note, in a recent study76a mismatch repair protein alteration was found not uncommonly in those with focal mucin production but was very uncommon in those with more profuse mucin formation.

Poorly cohesive cell carcinomas (with or without signet ring cells) are rare.7779 Unlike mucinous adenocarcinomas, the signet ring cells are individually arranged and infiltrate the stroma in a single-file pattern resembling diffuse-type gastric adenocarcinomas (see Fig. 41.18). Significant extracellular mucin pools are absent. A poorly cohesive cell pattern may be found in other types of ampullary adenocarcinomas. However, this diagnosis is applied when more than 50% of the tumor volume consists of these elements. The differential diagnosis includes metastases from the stomach or breast (i.e., lobular carcinoma). The latter can be distinguished by immunohistochemical staining for hormone receptors. These tumors have gastric differentiation; most are positive for MUC5AC, and more than 50% are positive for MUC6. They usually lack intestinal differentiation; most are negative for CDX2, and staining for MUC2 is positive in only a few cases.79

Adenosquamous carcinomas contain glandular and squamous elements. Adenosquamous carcinomas comprise 1% to 3% of all ampullary primaries.38,80,81 Although any degree of glandular differentiation (in a predominantly squamous neoplasm) is considered sufficient for a diagnosis of adenosquamous carcinoma, by convention, at least 25% of an adenocarcinoma should exhibit squamous differentiation to qualify.15 The glandular areas usually resemble a pancreatobiliary-type adenocarcinoma. The squamous elements grow in sheets and nests, and they are composed of polygonal cells with a generous amount of eosinophilic cytoplasm. Keratinization is usually evident. In cases with a predominantly squamous pattern, stains for mucin may help to identify areas of glandular differentiation. Squamous areas are often positive for P63 or K903.

Clear cell carcinomas resemble renal cell carcinomas, including the characteristic sinusoidal vascular pattern. However, mucin production is also evident.

Micropapillary carcinomas as described in the breast, urinary bladder, and other organs (characterized by small clusters of cells lying within clefts) can occur in the ampulla (see Fig. 41.19).82,83 This can be a focal finding, but it may occasionally be the predominant pattern. In one study, these tumors were found to be aggressive.48

Carcinomas with neuroendocrine differentiation can arise in adenocarcinomas of the ampulla. When the neuroendocrine component is substantial (>50%), the lesion is classified as a high-grade (poorly differentiated) neuroendocrine carcinoma (discussed later). There is emerging evidence in the remainder of the gastrointestinal tract that it may be important to recognize even a small neuroendocrine component, as long as it is convincing. Cis-platinum based therapy may have to be considered for such cases.

Other uncommon carcinomas can occur in the ampulla. Some ampullary adenocarcinomas are too poorly differentiated to permit classification as one of the previously described types. They may be assigned to the group of poorly differentiated, NOS adenocarcinomas (see Fig. 41.20). Rarely, sarcomatoid differentiation may occur in the form of a spindle cell carcinoma (i.e., sarcomatoid carcinoma) or as a biphasic neoplasm showing well-defined glandular elements mixed with distinct sarcomatoid elements (i.e., carcinosarcoma). In both cases, the sarcomatoid region often retains epithelial differentiation (i.e., immunoexpression of keratins). Undifferentiated carcinomas with osteoclast-like giant cells, identical to those that occur in the pancreas, rarely develop in the ampulla.84

Staging of Ampullary Carcinomas

The AJCC TNM staging manual of ampullary cancers defines parameters for the T stage.39 A T1 tumor is confined to the sphincter of Oddi, a T2 tumor invades the duodenum, a T3 tumor invades the pancreas, and a T4 tumor invades peripancreatic soft tissue (Table 41.5). Although this system is useful for intraampullary carcinomas, it is a challenge for ampullary carcinomas that arise from other compartments of this organ.85 For example, a minute carcinoma located in the Papilla of Vater (see Fig. 41.7) is classified as T2 (because of duodenal involvement), but a much larger intraampullary carcinoma confined to the sphincter of Oddi is classified as T1. This may explain why survival rates for T1 tumors are worse than those for T2 tumors according to the AJCC document.39 It has been proposed to stage the cases with duodenal submucosal involvement as T1b.85a

The AJCC TNM staging scheme presumes that the ampulla is (concentrically) surrounded by the duodenum and pancreas. However, in the posterior aspect, there is no pancreatic tissue, and ampullary carcinomas may invade directly into the periduodenal or peripancreatic soft tissues and duodenal serosa5a (Fig. 41.21). A significant proportion of ampullary carcinomas involves this anatomic region. Some authorities classify these tumors as duodenal and report periduodenal soft tissue involvement as T3 and serosal involvement as T4.85

Neuroendocrine Neoplasms and Related Tumors

Neuroendocrine cells are uncommon within the pancreatobiliary portion of the ampulla.86 The overlying duodenal epithelium contains the same amount of neuroendocrine cells as the surrounding nonampullary duodenal mucosa. Nevertheless, a variety of neuroendocrine neoplasms occur in the ampulla.

Ampullary neuroendocrine neoplasms are divided into well-differentiated and poorly differentiated categories, which do not appear to be closely related. Well-differentiated neuroendocrine neoplasms are essentially carcinoid tumors (Fig. 41.22), although some have distinct clinical and pathologic features. In addition to carcinoid-type tumors, not otherwise specified, clinically functional gastrinomas may arise within the periampullary region, as well as histologically distinctive glandular duodenal carcinoids, which contain somatostatin. These tumors have been called ampullary somatostatinomas (Fig. 41.23). A distinct but related entity is gangliocytic paraganglioma, a neoplasm that combines features of a carcinoid tumor with those of a nerve sheath tumor (Fig. 41.24). Poorly differentiated neuroendocrine carcinomas include small cell (Fig. 41.25) and large cell variants.

Well-Differentiated Neuroendocrine Tumors

Clinical Features

Well-differentiated neuroendocrine tumors (WDNETs), previously referred to as carcinoids, comprise approximately 3% of all tumors in the ampulla. They arise in adults in their 40s and 50s and have a male predominance.8790 Most are solitary and sporadic, but this region is a common site of WDNETs in multiple endocrine neoplasia (MEN) I, including gastrinomas associated with Zollinger-Ellison syndrome.9193 Ampullary somatostatinomas develop in patients with neurofibromatosis.9499

Most ampullary and duodenal WDNETs are clinically nonfunctional, with the exception of gastrinomas. Somatostatin-producing pseudoglandular tumors are not clinically functional, in contrast to some that occur within the pancreas.89,98,100,101 Carcinoid syndrome is rare.89

The clinical presentation is similar to that of other types of ampullary tumors.89,90,102 Duodenal gastrinomas may be difficult to identify clinically because of their small size. In patients with MEN I, it can be difficult to determine which of the multiple, small neuroendocrine neoplasms in the pancreas and duodenum are functional.103 Because most sporadic gastrinomas arise in the head of the pancreas or duodenum (or, rarely, within the peripancreatic lymph nodes), pancreatoduodenectomy has been advocated for patients with Zollinger-Ellison syndrome to remove the gastrinoma triangle.91 Because most pancreatic gastrinomas are sizable, the ampulla and duodenum in the gastrinoma triangle are the primary locations for most grossly inapparent tumors.103

Pathologic Features

WDNETs are usually small (3 cm in diameter or less), well-demarcated, submucosal nodules composed of uniform, tan tissue.88 Those arising in the ampulla may surround the distal pancreatic and bile ducts. Histologically, most nonfunctional cases (e.g., gastrinomas) are indistinguishable. They resemble their counterparts from other parts of the gastrointestinal (GI) tract, such as the stomach or pancreas (see Fig. 41.22).88 Typically, nests and ribbons of uniform cells are surrounded by some degree of hyalinized stroma. Despite being well circumscribed, these tumors usually infiltrate the surrounding tissues, entrap periampullary ductules within the tumor, and produce lymph node metastases, particularly by tumors that are larger than 2 cm in the greatest dimension. Individual cells have a modest amount of pale to eosinophilic cytoplasm. The nuclei are uniform in size and shape and contain stippled chromatin. The proliferative rate is usually low. Most cases have fewer than 10 mitoses per 10 high-power fields, and many cases have no more than 1 to 2 mitoses per 10 high-power fields. Necrosis may be focal and punctate, but it is usually absent.

Ampullary somatostatinomas (i.e., glandular psammo­matous neuroendocrine tumor of the duodenum) have distinctive features (see Fig. 41.23).88,9599,104,105 Although examination of any type of WDNET can reveal focal lumen formation, ampullary somatostatinomas are extensively gland forming. They usually show individual tubular glands that infiltrate the stroma (see Fig. 41.23). Some cribriform glands may also occur. The tumor cells have relatively abundant cytoplasm, which is eosinophilic and finely granular. Psammoma bodies are often found within glandular lumina, and luminal mucin may be seen. In some cases, the nuclei are basally oriented and uniform in appearance. The mitotic rate is low. Ampullary somatostatinomas have more frequent metastases than other types of duodenal WDNETs in this region.88 In approximately one fourth of patients, ampullary somatostatinomas are associated with neurofibromatosis. In some cases, neurofibromatosis is evident in the resection specimen because of abnormal nerves that have a spectrum of neurofibroma-like changes or because an incidental gastrointestinal stromal tumor is found.94,95,97,99,100,104 A distinctive type of sclerotic change within uninvolved blood vessels has been identified in ampullary somatostatinomas.

On immunohistochemical staining, all of these tumors express neuroendocrine markers such as chromogranin and synaptophysin. Staining for keratin is also positive. A variety of peptides and bioamines can be detected, even in cases that are clinically nonfunctional.88,95,98,106109 Gastrinomas usually label for gastrin, and somatostatinomas typically express somatostatin. The Ki67 labeling index for all types of duodenal and ampullary WDNETs is usually less than 10%.

Differential Diagnosis

The differential diagnosis depends on the specific histology of the tumor. Cases that show a nested or trabecular architecture may be confused with a poorly differentiated neuroendocrine carcinoma, but the latter neoplasms have a high mitotic rate (more than 10 mitoses per 10 high-power fields), extensive necrosis, and nuclear pleomorphism. The Ki67 labeling index is typically greater than 50%.110 Gland-forming examples may resemble adenocarcinomas, but the lack of a high degree of nuclear atypia, mitotic activity, and intracellular mucin helps to separate adenocarcinomas from carcinoid tumors. Gland-forming somatostatinomas can be mistaken for normal Brunner glands in endoscopic biopsies.

Poorly Differentiated Neuroendocrine Carcinoma

Poorly differentiated (high-grade) neuroendocrine carcinomas are categorized as small cell or large cell types. They are uncommon carcinomas of the ampulla, but based on the numbers of reported cases, they are more common in this anatomic location than in the pancreas.71,123131

The clinical features are similar to other types of ampullary carcinomas.131 The mean age at diagnosis is 69 years, and most patients are men. Many cases of poorly differentiated neuroendocrine carcinomas are associated with ampullary adenomas, and an adenocarcinoma component may be found.

The histologic features resemble those that arise in the lung. Small cell carcinomas contain sheets and nests of small cells with minimal cytoplasm, fusiform nuclei, finely granular chromatin, and inconspicuous nucleoli (see Fig. 41.25). Focal squamous differentiation may occur.132 Large cell neuroendocrine carcinomas possess larger cells with moderate amounts of cytoplasm and round to oval nuclei, often with prominent nucleoli.

The high-grade nature of poorly differentiated neuroendocrine carcinomas is reflected in their high proliferation rate, which is usually more than 10 mitoses per 10 high-power fields (by definition) and often in the range of 40 to 60 in large cell neuroendocrine carcinoma to more than 80 in small cell carcinoma. The Ki67 labeling index for these tumors is typically more than 50%.110 Necrosis is usually extensive. Both types of tumors immunostain for chromogranin and synaptophysin, although this is typically more focal than in well-differentiated neuroendocrine neoplasms. A diagnosis of small cell carcinoma does not require expression of neuroendocrine markers when classic cytologic features are evident.

These tumors are highly aggressive. Rapid dissemination and death from disease usually occurs within 2 years of diagnosis.127,129

Gangliocytic Paraganglioma

Gangliocytic paraganglioma is a rare tumor that occurs almost exclusively in the ampullary region (Fig. 41.24). Patient age at diagnosis varies widely (mean, 53 years), and men are affected more often than women.88,111113 Most gangliocytic paragangliomas are benign, and cases with metastases are rare.

Gangliocytic paragangliomas are usually 1 to 3 cm in diameter, nodular, and occur in the submucosa within a few centimeters of the ampulla. Some are pedunculated.15 Microscopically, gangliocytic paragangliomas contain three distinct cellular components, although in proportions that vary widely between cases and even within an individual tumor (see Fig. 41.24). Carcinoid-like elements form nests and ribbons of cells. They resemble cells of a typical carcinoid tumor or paraganglioma. Scattered, large, ganglion-like cells contain large nuclei with prominent nucleoli and granular cytoplasm. Spindle cells resemble peripheral nerve elements, and they may contain Schwann cells. The various cellular components are usually intimately intermixed, although some cases may show a rather sharp segregation between the different cellular elements.

Each component has a different immunohistochemical staining pattern.114119 Epithelioid cells are usually keratin positive, although often not as diffusely as typical carcinoid tumors. Staining for chromogranin, synaptophysin, pancreatic polypeptide, and somatostatin is usually positive. Other peptides, such as vasoactive intestinal polypeptide and glucagon, are less frequently positive. Ganglion-like cells express only synaptophysin; staining for keratin and chromogranin is negative. The spindle cell component stains positively for S100 protein and neurofilaments. These findings suggest that gangliocytic paragangliomas contain elements of endodermal (i.e., carcinoid-like cells) and neuroectodermal (i.e., Schwann and ganglion-like cells) origin, which is an unusual combination of findings that has evoked some intriguing hypotheses regarding the possible origin.112114,119,120

Consistent expression of pancreatic polypeptide, which is normally produced by islet cells derived from the embryonic ventral lobe of the gland, and the location of gangliocytic paragangliomas along the course of developmental migration of the ventral pancreas suggest a relationship to pancreatic development. However, it is unknown why these tumors occur only in the duodenum and not in the pancreas. Other investigators have suggested a relationship to an embryonic structure, the sympathetico-insular complex, which contains islet cells and branches of sympathetic nerves, including ganglion cells.119,121

Some have proposed that only the epithelial component of gangliocytic paragangliomas is truly neoplastic. The neuroectodermal components may be reactive and derived from the myenteric plexus. However, the observation of Schwann cell elements within metastases argues against this theory. Even when metastatic, these tumors seem to be benevolent.114,117,122

Mesenchymal Neoplasms

Few types of mesenchymal neoplasms arise specifically in the ampulla. Tumors of the duodenal wall, such as GI stromal tumors or submucosal lipomas, may involve the ampulla secondarily and manifest clinically with obstructive jaundice.15 Neurofibroma, ganglioneuroma, rhabdomyosarcoma, and Kaposi sarcoma have been reported in the ampullary region, and their pathologic features are similar to those that arise in other anatomic locations.133139 Sarcomas should be distinguished from sarcomatoid carcinomas, which are more common and show immunohistochemical evidence of epithelial differentiation (i.e., keratin expression) and a separate, morphologically recognizable carcinoma component.

Tumor-like Lesions

A variety of tumor-like lesions can involve the ampulla and simulate a neoplasm clinically, radiographically, and sometimes pathologically.

Paraduodenal Pancreatitis

Paraduodenal pancreatitis140143 is a distinctive variant of pancreatitis that occurs in the duodenal wall adjacent to pancreatic tissue (Fig. 41.26). It often centers on the accessory duct and minor ampulla. Paraduodenal pancreatitis is the most common cause of a benign condition that is mistaken for cancer. A significant proportion of paraduodenal pancreatitis cases are initially diagnosed as periampullary cancer or pancreatic cancer, a phenomenon previously referred to as groove pancreatitis or cystic dystrophy in heterotopic pancreas.

Paraduodenal pancreatitis is characterized by an exuberant myofibroblastic proliferation arranged in fascicles. The process narrows the duodenal lumen and scars the duodenal wall. The duodenal mucosa often acquires a nodular or cobblestone appearance. The duodenal mucosa is often thickened and contains Brunner gland hyperplasia in addition to myoid hyperplasia. On sectioning, the duodenal wall musculature, especially in the vicinity of the minor ampulla, has a trabeculated appearance that is often accompanied by a cystic change. In some cases, cyst formation may be prominent, with lesions as large as several centimeters in diameter (i.e., paraduodenal wall cysts) (Fig. 41.27).

Microscopic examination often reveals round (well-circumscribed), small lobules of pancreatic tissue (i.e., myoadenomatosis pattern) or various sizes of ducts (i.e., cystic dystrophy in heterotopic pancreas) scattered among myoid stromal cells. These ducts may contain inspissated acinar enzymes. Some cysts are devoid of epithelium. Instead, they are lined by a more cellular fibroblastic tissue. Occasionally, the lining fibroblasts may appear epithelioid and raise concern about the possibility of a sarcomatoid carcinoma. The cystic contents may extravasate and cause a foreign-body giant cell reaction and stromal eosinophilia.143

Overall, clinically, the lesion displays several stigmata associated with cancer, including a highly infiltrative appearance, dilation of the common bile duct, and narrowing of portal and mesenteric blood vessels. A tubulocystic change in the vicinity of the accessory duct and duodenal wall (in the minor ampullary region) are highly specific features seen on magnetic resonance imaging.

The reasons this process develops mainly around the minor (accessory) ampulla or accessory duct are unknown. In some cases, pancreas divisum (i.e., persistence of embryologic-type, dorsal-ventral separation of drainage systems) is suspected. One possibility is occlusion of a functionally overactive accessory duct (by unknown mechanisms), perhaps triggered by alcohol abuse. However, the macroscopic and microscopic morphologic findings are quite distinctive.

This process appears to have some consistent clinical associations. Most patients are young men in their 40s. Patients often have a history of alcohol abuse, and some have a history of hypertension.

Adenomyomatous Hyperplasia

Adenomyomatous hyperplasia of the ampulla (i.e., adenomyoma) may mimic carcinoma. In some studies, 60% of autopsy cases had this lesion.144 Some pathologists define this entity as having at least a 5-mm thickness of the ampullary musculature. Because the normal ampulla contains tubules within dense muscular tissue (see Fig. 41.1, B), it is difficult to determine specific criteria for adenomyomatous hyperplasia.

In some patients with obstructive jaundice and a suspected tumor in the ampulla, the only pathologic finding proves to be a thickened or exaggerated ampulla (Fig. 41.28). The diagnosis relies heavily on clinical findings, particularly raised intraampullary pressure, combined with exclusion of other pathologic conditions.

Other Tumor-Like Conditions

Papillary hyperplasia (Fig. 41.29) is a poorly characterized type of intraampullary lesion that consists of an exaggeration of the normal papillae.15 The papillae are lined by biliary-type epithelium and sometimes contain an expanded fibrovascular core. Cases with inflammation may also have reactive epithelial changes. However, the degree of nuclear pseudostratification characteristic of intestinal-type adenomas and the marked degree of atypia of true papillary neoplasms are absent in this condition. The diagnosis rests on the recognition that the extent of papilla formation exceeds that normally found in the ampulla.

Pancreatic heterotopia can occur throughout the upper GI tract, including the ampulla of Vater,145,146 although symptomatic cases at this anatomic site are rare. Pancreatic acini, ducts, and islets are found adjacent to ducts within the muscularis of the sphincter of Oddi. Pancreatic tissue is commonly associated with the minor ampulla and represents residua from involution of the terminal ventral embryonic pancreatic duct. In some cases, there is no acinar or neuroendocrine tissue, only scattered ducts, which are usually embedded within hyperplastic smooth muscle bundles. Brunner gland hyperplasia, which consists of nodules of histologically normal Brunner glands mixed with smooth muscle fibers, also can affect the ampulla.147149

Gross Evaluation and the Surgical Pathology Report

Classification of ampullary tumors and their differentiation from neoplasms of nearby sites rely heavily on gross examination.5a Opening the duodenum along the antiampullary side and placing a probe into and through the common bile duct to locate the ampullary orifice in the lesion provides the key findings. For example, ampullary duodenal tumors most often form large, variegated, ulcerovegatative lesions on the duodenal surface of the ampulla with an eccentric location of the orifice. IAPNs typically have a centrally located orifice with evenly distributed granular or polypoid protrusions into the duodenal lumen. The ampullary duct cases show minimal changes and are often covered by mucosa, and the common bile duct is usually difficult to probe.

Different methods may be used to section the ampulla as long as all the important parameters are documented. Transverse (amputative) sectioning of the ampulla may allow documentation of intraampullary tumor spread beyond the sphincter of Oddi. However, this approach typically fails to capture the extent of a carcinoma that arises from the edge of the papilla of Vater. Evaluation of the groove region (i.e., posterior aspect of the ampulla that is not covered by pancreatic tissue) usually requires specific attention to this area. It is advisable to ink the pancreatoduodenal soft tissue, open the ducts, and obtain a perpendicular section, including the tumor with the duodenal serosa.

Standard information should be included in the surgical pathology report for ampullary carcinomas. Site-specific classification should be provided as ampullary-NOS, ampullary duodenum, ampullary duct, or IAPN-associated tumors (see Fig. 41.6). Histologic typing of carcinoma as intestinal (see Fig. 41.15), pancreatobiliary (see Fig. 41.16), or others should be provided separately, if feasible. Cases with unclassifiable patterns should be documented as such. For mixed-pattern cases, the types identified in the diagnostic section and their proportions should be provided in a comment. For cases with a preinvasive (adenomatous) component, the available characteristics should be provided separately, including the location (i.e., ampullary duodenal adenoma or IAPN), size, and cell lineage.

The size of an invasive carcinoma should be documented separately by direct measurement or estimation of the percentage of the overall tumor.4,150 In staging ampullary carcinomas, most investigators still report duodenal involvement (including duodenal mucosal involvement) as T2, although this leads to serious overstaging of small tumors arising in the papilla of Vater (because they also involve the duodenal mucosa), and all ampullary duodenal cases become T2 by default.85 Staging protocols are under development for these cases.151 For cases with invasion into the periduodenal soft tissue at the groove area, most authorities advocate designating them as T3, not T4 (i.e., not as peripancreatic soft tissue). Duodenal serosal involvement should be regarded as T4, as is the case for any other GI organ.85

Reporting of ampullary carcinomas should include all the conventional parameters for cancer reporting, such as vascular and perineural invasion, margin status, and lymph node status. A pancreatoduodenectomy specimen typically contains more than 12 lymph nodes.5a,152 Orange peeling of the peripancreatic soft tissues before sectioning the pancreatic head can help to ensure maximal node recovery, because the lymph nodes are typically embedded in the surface indentations of the pancreas and can be difficult to harvest after the specimen has been dissected.152

Acknowledgment

We are indebted to Dr. Serdar Balci, Dr. Burcu Saka, Dr. Pelin Bagci, Ms. Rhonda Everett, and Ms. Leslie Ducato for their extensive contributions in the preparation of this chapter.

References

1. Roggin KK, Yeh JJ, Ferrone CR, et al. Limitations of ampullectomy in the treatment of nonfamilial ampullary neoplasms. Ann Surg Oncol. 2005;12:971–980.

2. Ceppa EP, Burbridge RA, Rialon KL, et al. Endoscopic versus surgical ampullectomy: an algorithm to treat disease of the ampulla of Vater. Ann Surg. 2013;257:315–322.

3. Choi YR, Han JH, Cho YS, et al. Efficacy of cap-assisted endoscopy for routine examining the ampulla of Vater. World J Gastroenterol. 2013;19:2037–2043.

4. Adsay V, Ohike N, Tajiri T, et al. Ampullary region carcinomas: definition and site specific classification with delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases. Am J Surg Pathol. 2012;36:1592–1608.

5. Cubilla LA, Fitzgerald PJ. Tumors of the exocrine pancreas. [2nd Series, Fascicle 19] Atlas of Tumor Pathology. Armed Forces Institute of Pathology: Washington, DC; 1984.

5a. Adsay NV, Basturk O, Saka B, et al. Whipple made simple for surgical pathologists: orientation, dissection, and sampling of pancreaticoduodenectomy specimens for a more practical and accurate evaluation of pancreatic, distal common bile duct, and ampullary tumors. Am J Surg Pathol. 2014;38:480–489.

6. Kozu T, Suda K, Toki F. Pancreatic development and anatomical variation. Gastrointest Endosc Clin North Am. 1995;5:1–30.

7. Solcia E, Capella C, Kloppel G. Tumors of the pancreas. [3rd Series, Fascicle 20] Atlas of Tumor Pathology. Armed Forces Institute of Pathology: Washington, DC; 1997.

8. Klimstra DS, Hruban RH, Pitman MB. Pancreas. Mills S. Histology for Pathologists. Lippincott Williams & Wilkins: Philadelphia; 2006:723–760.

9. Noda Y, Watanabe H, Iwafuchi M, et al. Carcinoids and endocrine cell micronests of the minor and major duodenal papillae. Their incidence and characteristics. Cancer. 1992;70:1825–1833.

10. Ozdemir D, Saka B, Bagci P, et al. Histology and histopathology of minor papilla (accessory ampulla): an analysis of 160 cases with emphasis on features with potential impact on daily surgical pathology practice. Mod Pathol. 2013;26:171A.

11. He J, Ahuja N, Makary MA, et al. 2564 resected periampullary adenocarcinomas at a single institution: trends over three decades. HPB (Oxford). 2014;16:83–90.

12. Overman MJ, Zhang J, Kopetz S, et al. Gene expression profiling of ampullary carcinomas classifies ampullary carcinomas into biliary-like and intestinal-like subtypes that are prognostic of outcome. PLoS One. 2013;8:e65144.

13. Washington K, Berlin J, Branton P, et al. Protocol for the examination of specimens from patients with carcinoma of the ampulla of Vater. [for the College of American Pathologists (CAP)]  <http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2012/Ampulla_12protocol_3101.pdf>; 2012 [Accessed January 24, 2014] .

14. Ohike N, Kim GE, Tajiri T, et al. Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 cases. Am J Surg Pathol. 2010;34:1731–1748.

15. Albores-Saavedra J, Henson DE, Klimstra DS. Tumors of the gallbladder, extrahepatic bile ducts, and ampulla of Vater. [3rd Series, Fascicle 27] Atlas of Tumor Pathology. Armed Forces Institute of Pathology: Washington, DC; 2000.

16. Perzin KH, Bridge MF. Adenomas of the small intestine: a clinicopathologic review of 51 cases and a study of their relationship to carcinoma. Cancer. 1981;48:799–819.

17. Alexander JR, Andrews JM, Buchi KN, et al. High prevalence of adenomatous polyps of the duodenal papilla in familial adenomatous polyposis. Dig Dis Sci. 1989;34:167–170.

18. Domizio P, Talbot IC, Spigelman AD, Williams CB, Phillips RK. Upper gastrointestinal pathology in familial adenomatous polyposis: results from a prospective study of 102 patients. J Clin Pathol. 1990;43:738–743.

19. Noda Y, Watanabe H, Iida M, et al. Histologic follow-up of ampullary adenomas in patients with familial adenomatosis coli. Cancer. 1992;70:1847–1856.

20. Odze R, Gallinger S, So K, Antonioli D. Duodenal adenomas in familial adenomatous polyposis: relation of cell differentiation and mucin histochemical features to growth pattern. Mod Pathol. 1994;7:376–384.

21. Yao T, Ida M, Ohsato K, Watanabe H, Omae T. Duodenal lesions in familial polyposis of the colon. Gastroenterology. 1977;73:1086–1092.

22. Shemesh E, Bat L. A prospective evaluation of the upper gastrointestinal tract and periampullary region in patients with Gardner syndrome. Am J Gastroenterol. 1985;80:825–827.

23. Cattell RB, Pyrtek LJ. Premalignant lesions of the ampulla of Vater. Surg Gynecol Obstet. 1950;90:21–30.

24. Oh C, Jemerin EE. Benign adenomatous polyps of the papilla of Vater. Surgery. 1965;57:495–503.

25. Rosenberg J, Welch JP, Pyrtek LJ, Walker M, Trowbridge P. Benign villous adenomas of the ampulla of Vater. Cancer. 1986;58:1563–1568.

26. Sobol S, Cooperman AM. Villous adenoma of the ampulla of Vater. An unusual cause of biliary colic and obstructive jaundice. Gastroenterology. 1978;75:107–109.

27. Blackman E, Nash SV. Diagnosis of duodenal and ampullary epithelial neoplasms by endoscopic biopsy: a clinicopathologic and immunohistochemical study. Hum Pathol. 1985;16:901–910.

28. Yamaguchi K, Enjoji M. Adenoma of the ampulla of Vater: putative precancerous lesion. Gut. 1991;32:1558–1561.

29. Polydorides AD, Shia J, Tang LH, Klimstra DS, et al. An immunohistochemical panel distinguishes colonization by pancreatic ductal adenocarcinoma from adenomas of ampullary and duodenal mucosa [abstract]. Mod Pathol. 2008;21:132A.

30. Morini S, Perrone G, Borzomati D, et al. Carcinoma of the ampulla of Vater: morphological and immunophenotypical classification predicts overall survival. Pancreas. 2013;42:60–66.

31. Ferrell LD, Beckstead JH. Paneth-like cells in an adenoma and adenocarcinoma in the ampulla of Vater. Arch Pathol Lab Med. 1991;115:956–958.

32. Baczako K, Büchler M, Beger HG, Kirkpatrick CJ, Haferkamp O. Morphogenesis and possible precursor lesions of invasive carcinoma of the papilla of Vater: epithelial dysplasia and adenoma. Hum Pathol. 1985;16:305–310.

33. Klöppel G, Adsay V, Konukiewitz B, et al. Precancerous lesions of the biliary tree. Best Pract Res Clin Gastroenterol. 2013;27:285–297.

34. Klimstra DS, Albores-Saavedra J, Hruban RH, et al. Tumours of the ampullary region, adenomas and other premalignant neoplastic lesions. Bosman FT, Carneiro F, Hruban RH, et al. WHO Classification of Tumours of the Digestive System. IARC: Lyon, France; 2010:83–86.

35. Adsay V, Jang KT, Roa JC, et al. Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases. Am J Surg Pathol. 2012;36:1279–1301.

36. Jones BA, Langer B, Taylor BR, Girotti M. Periampullary tumors: which ones should be resected? Am J Surg. 1985;149:46–52.

37. Martin FM, Rossi RL, Dorrucci V, Silverman ML, Braasch JW. Clinical and pathologic correlations in patients with periampullary tumors. Arch Surg. 1990;125:723–726.

38. Warren KW, Choe DS, Plaza J, Relihan M. Results of radical resection for periampullary cancer. Ann Surg. 1975;181:534–540.

39. Edge SE. Ampulla of Vater. Edge SE, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual and Handbook. 7th ed. Springer: New York; 2010:235–240.

40. Komorowski RA, Cohen EB. Villous tumors of the duodenum: a clinicopathologic study. Cancer. 1981;47:1377–1386.

41. Longmire WP Jr. Periampullary tumours. J R Coll Surg Edinb. 1973;18:131–136.

42. Makipour H, Cooperman A, Danzi JT, Farmer RG. Carcinoma of the ampulla of Vater: review of 38 cases with emphasis on treatment and prognostic factors. Ann Surg. 1976;183:341–344.

43. Treadwell TA, Jimenez-Chapa JF, White RR 3rd. Carcinoma of the ampulla of Vater. South Med J. 1978;71:365–367.

44. Akwari OE, van Heerden JA, Adson MA, Baggenstoss AH. Radical pancreatoduodenectomy for cancer of the papilla of Vater. Arch Surg. 1977;112:451–456.

45. Wise L, Pizzimbono, Dehner LP. Periampullary cancer. A clinicopathologic study of sixty-two patients. Am J Surg. 1976;131:141–148.

46. Kimura W, Futakawa N, Yamagata S, et al. Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater. Jpn J Cancer Res. 1994;85:161–166.

47. Talbot IC, Neoptolemos JP, Shaw DE, Carr-Locke D. The histopathology and staging of carcinoma of the ampulla of Vater. Histopathology. 1988;12:155–165.

48. Khayyata S, Basturk O, Adsay NV. Invasive micropapillary carcinomas of the ampullo-pancreatobiliary region and their association with tumor-infiltrating neutrophils. Mod Pathol. 2005;18:1504–1511.

49. Mora JI, Barroeta JE, Bernstein DA, Lechago J. Paneth cell carcinoma of the ampulla of Vater. Arch Pathol Lab Med. 2004;128:908–910.

49a. Balci S, Kim G, Ohike N, et al. Applicability and prognostic relevance of ampullary carcinoma histologic typing as pancreatobiliary versus intestinal (Abstract). Mod Pathol. 2010;23:350A.

50. Ohike N, Coban I, Kim GE, et al. Tumor budding as a strong prognostic indicator in invasive ampullary adenocarcinomas. Am J Surg Pathol. 2010;34:1417–1424.

51. Sessa F, Furlan D, Zampatti C, et al. Prognostic factors for ampullary adenocarcinomas: tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability. Virchows Arch. 2007;451:649–657.

52. Moore PS, Orlandini S, Zamboni G, et al. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis. Br J Cancer. 2001;84:253–262.

53. Chung CH, Wilentz RE, Polak MM, et al. Clinical significance of K-ras oncogene activation in ampullary neoplasms. J Clin Pathol. 1996;49:460–464.

54. Finkelstein SD, Sayegh R, Christensen S, Swalsky PA. Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type. Cancer. 1993;71:3827–3838.

55. Howe JR, Klimstra DS, Cordon-Cardo C, et al. K-ras mutation in adenomas and carcinomas of the ampulla of Vater. Clin Cancer Res. 1997;3:129–133.

56. Malats N, Porta M, Piñol JL, Corominas JM, Rifà J, Real FX. Ki-ras mutations as a prognostic factor in extrahepatic bile system cancer. PANK-ras I Project Investigators. J Clin Oncol. 1995;13:1679–1686.

57. Scarpa A, Capelli P, Zamboni G, et al. Neoplasia of the ampulla of Vater. Ki-ras and p53 mutations. Am J Pathol. 1993;142:1163–1172.

58. Shyr YM, Su CH, Wu LH, et al. Prognostic value of MIB-1 index and DNA ploidy in resectable ampulla of Vater carcinoma. Ann Surg. 1999;229:523–527.

59. Takashima M, Ueki T, Nagai E, et al. Carcinoma of the ampulla of Vater associated with or without adenoma: a clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohistochemical expressions. Mod Pathol. 2000;13:1300–1307.

60. Teh M, Wee A, Raju GC. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas. Cancer. 1994;74:1542–1545.

61. Achille A, Scupoli MT, Magalini AR, et al. APC gene mutations and allelic losses in sporadic ampullary tumours: evidence of genetic difference from tumours associated with familial adenomatous polyposis. Int J Cancer. 1996;68:305–312.

62. Kawakami M, Kimura Y, Furuhata T, et al. beta-Catenin alteration in cancer of the ampulla of Vater. J Exp Clin Cancer Res. 2002;21:23–27.

63. McCarthy DM, Hruban RH, Argani P, et al. Role of the DPC4 tumor suppressor gene in adenocarcinoma of the ampulla of Vater: analysis of 140 cases. Mod Pathol. 2003;16:272–278.

63a. Balci S, Saka B, Bagci P, et al. Medullary carcinomas of the ampulla: clinicopathologic analysis of 11 cases (Abstract). Mod Pathol. 2014;27:446A.

63b. Balci S, Saka B, Krasinskas A, et al. Clinicopathologic associations of mismatch repair protein expressions in ampullary carcinomas (Abstract). Mod Pathol. 2014;27:164A.

64. Agaram NP, Shia J, Klimstra DS. Ampullary carcinoma: role of DNA mismatch repair gene defects in pathogenesis [abstract]. Mod Pathol. 2005;18:272A.

65. Saka B, Tajari T, Ohike N, et al. Clinicopathologic comparison of ampullary versus pancreatic carcinoma: preinvasive component, size of invasion, stage, resectability and histologic phenotype are the factors for the significantly favorable outcome of ampullary carcinoma [abstract]. Mod Pathol. 2013;26:429A.

66. Gonzalez RS, Bagci P, Kong KT, et al. Distal common bile duct adenocarcinoma: analysis of 47 cases and comparison with pancreatic and ampullary ductal carcinomas [abstract]. Mod Pathol. 2012;25:443A.

67. Saka B, Bagci P, Krasinskas A, et al. Duodenal carcinomas of non-ampullary origin are significantly more aggressive than ampullary carcinomas [abstract]. Mod Pathol. 2013;26:176A–177A.

68. Howe JR, et al. Factors predictive of survival in ampullary carcinoma. Ann Surg. 1998;228(1):87–94.

69. Chang DK, Jamieson NB, Johns AL, et al. Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of Vater. J Clin Oncol. 2013;31:1348–1356.

70. Westgaard A, Pomianowska E, Clausen OP, Gladhaug IP. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies? Ann Surg Oncol. 2013;20:430–439.

71. Mori K, Ikei S, Yamane T, et al. Pathological factors influencing survival of carcinoma of the ampulla of Vater. Eur J Surg Oncol. 1990;16:183–188.

72. Sciallero S, Giaretti W, Geido E, et al. DNA aneuploidy is an independent factor of poor prognosis in pancreatic and peripancreatic cancer. Int J Pancreatol. 1993;14:21–28.

73. Shyr YM, Su CH, Wu LH, et al. DNA ploidy as a major prognostic factor in resectable ampulla of Vater cancers. J Surg Oncol. 1993;53:220–225.

74. Sperti C, Pasquali C, Piccoli A, Sernagiotto C, Pedrazzoli S. Radical resection for ampullary carcinoma: long-term results. Br J Surg. 1994;81:668–671.

75. Woo SM, Ryu JK, Lee SH, et al. Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma. Ann Surg Oncol. 2007;14:3195–3201.

76. Seifert E, Schulte F, Stolte M. Adenoma and carcinoma of the duodenum and papilla of Vater: a clinicopathologic study. Am J Gastroenterol. 1992;87:37–42.

76a. Jang K-T, Balci S, Bagci P, et al. Mucinous carcinomas of the ampulla: clinicopathologic analysis of 33 cases (Abstract). Mod Pathol. 2014;27:450A.

77. Purohit RC, Kant K, Bhargava N, Kothari N, Purohit V. Signet ring cell carcinoma of ampulla of Vater in a young adult. Indian J Gastroenterol. 2005;24:222–223.

78. Acharya MN, Panagiotopoulos N, Cohen P, Ahmad R, Jiao LR. Poorly-differentiated signet-ring cell carcinoma of the ampulla of Vater: report of a rare malignancy. JOP. 2013;14:190–194.

79. Bradley K, Jang K-T, Kim G, et al. Poorly cohesive carcinomas of the ampulla of Vater: analysis of 9 cases identified among 249 ampullary carcinomas [abstract]. Mod Pathol. 2012;25:156A.

80. Yamaguchi K, Enjoji M. Carcinoma of the ampulla of Vater. A clinicopathologic study and pathologic staging of 109 cases of carcinoma and 5 cases of adenoma. Cancer. 1987;59:506–515.

81. Yang SJ, Ooyang CH, Wang SY, et al. Adenosquamous carcinoma of the ampulla of Vater—a rare disease at unusual location. World J Surg Oncol. 2013;11:124.

82. Nassar H, Wallis T, Andea A, et al. Clinicopathologic analysis of invasive micropapillary differentiation in breast carcinoma. Mod Pathol. 2001;14:836–841.

83. Nassar H, Pansare V, Zhang H, et al. Pathogenesis of invasive micropapillary carcinoma: role of MUC1 glycoprotein. Mod Pathol. 2004;17:1045–1050.

84. Molberg KH, Heffess C, Delgado R, Albores-Saavedra J. Undifferentiated carcinoma with osteoclast-like giant cells of the pancreas and periampullary region. Cancer. 1998;82:1279–1287.

85. Adsay NV, Bagci P, Tajiri T, et al. Pathologic staging of pancreatic, ampullary, biliary, and gallbladder cancers: pitfalls and practical limitations of the current AJCC/UICC TNM staging system and opportunities for improvement. Semin Diagn Pathol. 2012;29:127–141.

85a. You DD, Heo JS, Choi SH, et al. Pathologic T1 subclassification of ampullary carcinoma with perisphincteric or duodenal submucosal invasion: is it T1b? Arch Pathol Lab Med. (In press).

86. Dancygier H, Klein U, Leuschner U, Hübner K, Classen M. Somatostatin-containing cells in the extrahepatic biliary tract of humans. Gastroenterology. 1984;86(pt 1):892–896.

87. Bornstein-Quevedo L, Gamboa-Dominguez A. Carcinoid tumors of the duodenum and ampulla of Vater: a clinicomorphologic, immunohistochemical, and cell kinetic comparison. Hum Pathol. 2001;32:1252–1256.

88. Burke AP, Federspiel BH, Sobin LH, Shekitka KM, Helwig EB. Carcinoids of the duodenum. A histologic and immunohistochemical study of 65 tumors. Am J Surg Pathol. 1989;13:828–837.

89. Hatzitheoklitos E, Büchler MW, Friess H, et al. Carcinoid of the ampulla of Vater. Clinical characteristics and morphologic features. Cancer. 1994;73:1580–1588.

90. Ricci JL. Carcinoid of the ampulla of Vater. Local resection or pancreaticoduodenectomy. Cancer. 1993;71:686–690.

91. Donow C, Pipeleers-Marichal M, Schröder S, et al. Surgical pathology of gastrinoma. Site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy. Cancer. 1991;68:1329–1334.

92. Sugimoto K, Oosawa S, Furuta T, et al. Multiple endocrine neoplasia type 1 accompanied by duodenal carcinoid tumors and hypergastrinemia: a familial case. Intern Med. 1995;34:649–653.

93. Yazawa K, Kuroda T, Watanabe H, et al. Multiple carcinoids of the duodenum accompanied by type I familial multiple endocrine neoplasia. Surg Today. 1998;28:636–639.

94. Barber PV. Carcinoid tumour of the ampulla of Vater associated with cutaneous neurofibromatosis. Postgrad Med J. 1976;52:514–517.

95. Dayal Y, Tallberg KA, Nunnemacher G, DeLellis RA, Wolfe HJ. Duodenal carcinoids in patients with and without neurofibromatosis. A comparative study. Am J Surg Pathol. 1986;10:348–3457.

96. Griffiths DF, Jasani B, Newman GR, Williams ED, Williams GT. Glandular duodenal carcinoid–a somatostatin rich tumour with neuroendocrine associations. J Clin Pathol. 1984;37:163–169.

97. Simmons TC, Henderson DR, Gletten F, Pascua L, Greene C. The association of neurofibromatosis, psammomatous ampullary carcinoid tumor, and extrahepatic biliary obstruction. J Clin Gastroenterol. 1987;9:490–492.

98. Stamm B, Hedinger CE, Saremaslani P. Duodenal and ampullary carcinoid tumors. A report of 12 cases with pathological characteristics, polypeptide content and relation to the MEN I syndrome and von Recklinghausen’s disease (neurofibromatosis). Virchows Arch A Pathol Anat Histopathol. 1986;408:475–489.

99. Wheeler MH, Curley IR, Williams ED. The association of neurofibromatosis, pheochromocytoma, and somatostatin-rich duodenal carcinoid tumor. Surgery. 1986;100:1163–1169.

100. Swinburn BA, Yeong ML, Lane MR, Nicholson GI, Holdaway IM. Neurofibromatosis associated with somatostatinoma: a report of two patients. Clin Endocrinol (Oxf). 1988;28:353–359.

101. Taccagni GL, Carlucci M, Sironi M, Cantaboni A, Di Carlo V. Duodenal somatostatinoma with psammoma bodies: an immunohistochemical and ultrastructural study. Am J Gastroenterol. 1986;81:33–37.

102. Mulder CJ, Festen HP, Mertens JC, et al. Carcinoid tumor of the ampulla of Vater presenting with biliary obstruction: report of four cases. Gastrointest Endosc. 1987;33:385–387.

103. Anlauf M, Enosawa T, Henopp T, et al. Primary lymph node gastrinoma or occult duodenal microgastrinoma with lymph node metastases in a MEN1 patient: the need for a systematic search for the primary tumor. Am J Surg Pathol. 2006;32:1101–1105.

104. Burke AP, Sobin LH, Shekitka KM, Federspiel BH, Helwig EB. Somatostatin-producing duodenal carcinoids in patients with von Recklinghausen’s neurofibromatosis. A predilection for black patients. Cancer. 1990;65:1591–1595.

105. Thirabonjasak D, Tang L, Klimsdtra DS, et al. Glandular carcinoids of the ampulla with psammoma bodies (so-called ampullary somatostatinomas): Analysis of 12 cases of an under-recognized entity [abstract]. Mod Pathol. 2008;21:137A.

106. Attanoos R, Williams GT. Epithelial and neuroendocrine tumors of the duodenum. Semin Diagn Pathol. 1991;8:149–162.

107. Mukai K, Grotting JC, Greider MH, Rosai J. Retrospective study of 77 pancreatic endocrine tumors using the immunoperoxidase method. Am J Surg Pathol. 1982;6:387–399.

108. Makhlouf HR, Burke AP, Sobin LH. Carcinoid tumors of the ampulla of Vater: a comparison with duodenal carcinoid tumors. Cancer. 1999;85:1241–1249.

109. Sanchez-Sosa S, Angeles Angeles A, Orozco H, Larriva-Sahd J. Neuroendocrine carcinoma of the ampulla of Vater. A case of absence of somatostatin in a vasoactive intestinal polypeptide-, bombesin-, and cholecystokinin-producing tumor. Am J Clin Pathol. 1991;95:51–54.

110. Sorbye H, Welin S, Langer SW, et al. Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study. Ann Oncol. 2013;24:152–160.

111. Reed RJ, Caroca PJ Jr, Harkin JC. Gangliocytic paraganglioma. Am J Surg Pathol. 1977;1:207–216.

112. Scheithauer BW, Nora FE, LeChago J, et al. Duodenal gangliocytic paraganglioma. Clinicopathologic and immunocytochemical study of 11 cases. Am J Clin Pathol. 1986;86:559–565.

113. Taylor HB, Helwig EB. Benign nonchromaffin paragangliomas of the duodenum. Virchows Arch Pathol Anat Physiol Klin Med. 1962;335:356–366.

114. Burke AP, Helwig EB. Gangliocytic paraganglioma. Am J Clin Pathol. 1989;92:1–9.

115. Barbareschi M, Frigo B, Aldovini D, et al. Duodenal gangliocytic paraganglioma. Report of a case and review of the literature. Virchows Arch A Pathol Anat Histopathol. 1989;416:81–89.

116. Collina G, Maiorana A, Trentini GP. Duodenal gangliocytic paraganglioma. Case report with immunohistochemical study on the expression of keratin polypeptides. Histopathology. 1991;19:476–478.

117. Dookhan DB, Miettinen M, Finkel G, Gibas Z. Recurrent duodenal gangliocytic paraganglioma with lymph node metastases. Histopathology. 1993;22:399–401.

118. Hamid QA, Bishop AE, Rode J, et al. Duodenal gangliocytic paragangliomas: a study of 10 cases with immunocytochemical neuroendocrine markers. Hum Pathol. 1986;17:1151–1157.

119. Perrone T, Sibley RK, Rosai J. Duodenal gangliocytic paraganglioma. An immunohistochemical and ultrastructural study and a hypothesis concerning its origin. Am J Surg Pathol. 1985;9:31–41.

120. Konok GP, Sanchez-Cassis G. Gangliocytic paraganglioma of the duodenum. Can J Surg. 1979;22:173–175.

121. Campenhout V. Contribution a l’etude de l’histogenese du pancreas chez quelques mammiferes. Les complexeses sympathico-insularies. Arch Biol (Liege). 1927;37:121–171.

122. Buchler M, Malfertheiner P, Baczako K, Krautzberger W, Beger HG. A metastatic endocrine-neurogenic tumor of the ampulla of Vater with multiple endocrine immunoreaction—malignant paraganglioma? Digestion. 1985;31:54–59.

123. Dawson PJ, Connolly MM. Influence of site of origin and mucin production on survival in ampullary carcinoma. Ann Surg. 1989;210:173–179.

124. Emory RE Jr, Emory TS, Goellner JR, Grant CS, Nagorney DM. Neuroendocrine ampullary tumors: spectrum of disease including the first report of a neuroendocrine carcinoma of non-small cell type. Surgery. 1994;115:762–766.

125. Lee CS, Machet D, Rode J. Small cell carcinoma of the ampulla of Vater. Cancer. 1992;70:1502–1504.

126. Michelassi F, Erroi F, Dawson PJ, et al. Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct. Ann Surg. 1989;210:544–554.

127. Nassar H, Albores-Saavedra J, Klimstra DS. High-grade neuroendocrine carcinoma of the ampulla of Vater: a clinicopathologic and immunohistochemical analysis of 14 cases. Am J Surg Pathol. 2005;29:588–594.

128. Sarker AB, Hoshida Y, Akagi S, et al. An immunohistochemical and ultrastructural study of case of small-cell neuroendocrine carcinoma in the ampullary region of the duodenum. Acta Pathol Jpn. 1992;42:529–535.

129. Swanson PE, Dykoski D, Wick MR, Snover DC. Primary duodenal small-cell neuroendocrine carcinoma with production of vasoactive intestinal polypeptide. Arch Pathol Lab Med. 1986;110:317–320.

130. Travis WD, Linnoila RI, Tsokos MG, et al. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol. 1991;15:529–553.

131. Zamboni G, Franzin G, Bonetti F, et al. Small-cell neuroendocrine carcinoma of the ampullary region. A clinicopathologic, immunohistochemical, and ultrastructural study of three cases. Am J Surg Pathol. 1990;14:703–713.

132. Sugawara G, Yamaguchi A, Isogai M, et al. Small cell neuroendocrine carcinoma of the ampulla of Vater with foci of squamous differentiation: a case report. J Hepatobiliary Pancreat Surg. 2004;11:56–60.

133. Caty MG, Oldham KT, Prochownik EV. Embryonal rhabdomyosarcoma of the ampulla of Vater with long-term survival following pancreaticoduodenectomy. J Pediatr Surg. 1990;25:1256–1258.

134. Gemer M, Feuchtwanger MM. Ganglioneuroma of the duodenum. Gastroenterology. 1966;51:689–693.

135. Goldblum JR, Appelman HD. Stromal tumors of the duodenum. A histologic and immunohistochemical study of 20 cases. Am J Surg Pathol. 1995;19:71–80.

136. Isaacson C. Embryonal rhabdomyosarcoma of the ampulla of Vater. Cancer. 1978;41:365–368.

137. Klein A, Clemens J, Cameron J. Periampullary neoplasms in von Recklinghausen’s disease. Surgery. 1989;106:815–819.

138. Seitz JF, Giovannini M, Wartelle C, et al. Kaposi’s sarcoma of Vater’s ampulla associated with sclerosing cholangitis caused by Cryptosporidium in a patient with AIDS. Gastroenterol Clin Biol. 1990;14:889–891.

139. Wormsley KG, Logan WF, Sorrell VF, Cole GC. Neurofibromatosis with pancreatic duct obstruction and steatorrhoea. Postgrad Med J. 1967;43:432–435.

140. Adsay NV, Basturk O, Klimstra DS, Klöppel G. Pancreatic pseudotumors: non-neoplastic solid lesions of the pancreas that clinically mimic pancreas cancer. Semin Diagn Pathol. 2004;21:260–267.

141. Zamboni G, Capelli P, Scarpa A, et al. Nonneoplastic mimickers of pancreatic neoplasms. Arch Pathol Lab Med. 2009;133:439–453.

142. Kloppel G. Chronic pancreatitis, pseudotumors and other tumor-like lesions. Mod Pathol. 2007;20(suppl 1):S113–S131.

143. Adsay NV, Zamboni G. Paraduodenal pancreatitis: a clinico-pathologically distinct entity unifying “cystic dystrophy of heterotopic pancreas,” “para-duodenal wall cyst,” and “groove pancreatitis.”. Semin Diagn Pathol. 2004;21:247–254.

144. Handra-Luca A, Terris B, Couvelard A, Bonte H, Flejou JF. Adenomyoma and adenomyomatous hyperplasia of the Vaterian system: clinical, pathological, and new immunohistochemical features of 13 cases. Mod Pathol. 2003;16:530–536.

145. Blundell CR, Kanun CS, Earnest DL. Biliary obstruction by heterotopic gastric mucosa at the ampulla of Vater. Am J Gastroenterol. 1982;77:111–114.

146. Laughlin EH, Keown ME, Jackson JE. Heterotopic pancreas obstructing the ampulla of Vater. Arch Surg. 1983;118:979–980.

147. Fuller JW, Cruse CW, Williams JW. Hyperplasia of Brunner’s glands of the duodenum. Am Surg. 1977;43:246–250.

148. Skellenger ME, Kinner BM, Jordan PH Jr. Brunner’s gland hamartomas can mimic carcinoma of the head of the pancreas. Surg Gynecol Obstet. 1983;156:774–776.

149. Hol JW, Stuifbergen WN, Teepen JL, van Laarhoven CJ. Giant Brunner’s hamartomas of the duodenum and obstructive jaundice. An overview of the literature and suspicion of malignancy in a case. Dig Surg. 2007;24:452–455.

150. Tajiri T, Basturk O, Krasinskas A, et al. Prognostic differences between ampullary carcinomas and pancreatic ductal adenocarcinomas: the importance of size of invasive component [abstract]. Mod Pathol. 2009;22:323A.

151. Tajiri T, Coban I, Krasinskas A, et al. Proposal for a more applicable and clinically relevant staging evaluation of ampullary carcinomas [abstract]. Mod Pathol. 2011;24:69A.

152. Adsay NV, Basturk O, Altinel D, et al. The number of lymph nodes identified in a simple pancreatoduodenectomy specimen: comparison of conventional vs orange-peeling approach in pathologic assessment. Mod Pathol. 2009;22:107–112.